Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a loss of -16.03%.However, over the last six months, we can see a stronger performance of -10.86%. Over the last 30 days, the price of ZVRA has fallen by 12.24%. And in the last five days, it has fallen by -12.28%.
Zevra Therapeutics Inc’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $7.28 on 02/20/24, and the lowest price during that time was $3.89, recorded on 11/13/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of ZVRA Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Zevra Therapeutics Inc’s current trading price is -24.45% away from its 52-week high, while its distance from the 52-week low is 41.39%. The stock’s price range for this period has been between $3.89 and $7.28. The Healthcare sector company’s shares saw a trading volume of about 0.92 million for the day, which was higher than the average daily volume of 0.31 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Zevra Therapeutics Inc (ZVRA) has experienced a quarterly rise of 20.88% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 230.18M and boasts a workforce of 69 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.14, with a change in price of -0.75. Similarly, Zevra Therapeutics Inc recorded 289,107 in trading volume during the last 100 days, posting a change of -12.00%.
ZVRA’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for ZVRA stands at 0.91. Similarly, the long-term debt-to-equity ratio is also 0.90.
ZVRA Stock Stochastic Average
As of today, the raw stochastic average of Zevra Therapeutics Inc over the last 50 days is at 47.27%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 47.27%. Further, the company’s Stochastic %K and %D values for the last 20 days were 60.12% and 67.64%, respectively.
